Paul Scigalla

Hoofd Techniek/Wetenschap/O&O bij GENELUX CORPORATION

79 jaar

Health Technology

Consumer Services

Finance

Actieve functies van Paul Scigalla

Bedrijven	Functie	Begin	Einde
GENELUX CORPORATION	Hoofd Techniek/Wetenschap/O&O	01-09-2011	-
Ruprecht-Karls-Universität Heidelberg	Corporate Officer/Principal	01-01-1992	-

Bedrijven	Functie	Begin	Einde
Sugen, Inc. Sugen, Inc. Pharmaceuticals: MajorHealth Technology Sugen, Inc. developed small molecule drugs and related pharmaceutical products. The company was founded on July 1, 1991 and was headquartered in New York, NY.	Corporate Officer/Principal	01-01-1998	01-01-2001
NUEVOLUTION AB (PUBL)	Hoofd Techniek/Wetenschap/O&O	01-01-2018	-
DEUTSCHE BIOTECH INNOVATIV AG	Hoofd Techniek/Wetenschap/O&O	-	-

Humboldt-Universität zu Berlin

Doctorate Degree

Internationaal

Operationeel

Chief Tech/Sci/R&D Officer	3
Corporate Officer/Principal	2
Doctorate Degree	1

Sectoraal

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	2
DEUTSCHE BIOTECH INNOVATIV AG	Finance
GENELUX CORPORATION	Health Technology

Bedrijven in privébezit	2
Nuevolution AB Nuevolution AB Pharmaceuticals: MajorHealth Technology Nuevolution AB engages in pharmaceutical and biotechnology discovery. Its activities include research and development, and licensing drugs and treatment of oncology and chronic inflammatory diseases including cancer. It offers the platform Chemetics, which enables discovery of small molecule drug candidates for specific indications addressing target diseases. The company was founded by Henrik Pedersen, Alex Haahr Gouliaev, and Mads Nørregaard-Madsen in May 2001 and is headquartered in Copenhagen, Denmark.	Health Technology
Sugen, Inc. Sugen, Inc. Pharmaceuticals: MajorHealth Technology Sugen, Inc. developed small molecule drugs and related pharmaceutical products. The company was founded on July 1, 1991 and was headquartered in New York, NY.	Health Technology

Bedrijven in privébezit

Health Technology